Eli Lilly (LLY) Assets Average (2010 - 2026)

Eli Lilly (LLY) has reported Assets Average for 18 consecutive years, with $114.5 billion the latest figure, recorded in Q1 2026.

• Assets Average for Q1 2026 came in at $114.5 billion, up 36.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.5 billion (up 36.26% YoY), and the FY2025 annual result was $95.6 billion, up 33.96% from the prior year.
• Assets Average was $114.5 billion for Q1 2026 at Eli Lilly, up from $113.7 billion in the prior quarter.
• Over five years, Assets Average peaked at $114.5 billion in Q1 2026 and troughed at $47.0 billion in Q2 2022.
• Average Assets Average over 5 years is $71.3 billion, with a median of $64.0 billion recorded in 2024.
• Year-over-year, Assets Average dropped 1.53% in 2022 and jumped 47.36% in 2025.
• Over 5 years, Assets Average stood at $48.5 billion in 2022, then increased by 25.76% to $61.0 billion in 2023, then grew by 26.57% to $77.2 billion in 2024, then soared by 47.36% to $113.7 billion in 2025, then rose by 0.72% to $114.5 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $114.5 billion in Q1 2026, $113.7 billion in Q4 2025, and $107.9 billion in Q3 2025.